These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Echocardiographic prediction of patent ductus arteriosus in need of therapeutic intervention. Harling S, Hansen-Pupp I, Baigi A, Pesonen E. Acta Paediatr; 2011 Feb; 100(2):231-5. PubMed ID: 20874741 [Abstract] [Full Text] [Related]
11. Cardiovascular biomarkers in the evaluation of patent ductus arteriosus in very preterm neonates: A cohort study. Sellmer A, Hjortdal VE, Bjerre JV, Schmidt MR, Bech BH, Henriksen TB. Early Hum Dev; 2020 Oct; 149():105142. PubMed ID: 32861196 [Abstract] [Full Text] [Related]
15. Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Holmström H, Hall C, Thaulow E. Acta Paediatr; 2001 Feb; 90(2):184-91. PubMed ID: 11236049 [Abstract] [Full Text] [Related]
16. [Value of amino-terminal pro-brain natriuretic peptide as a predictive marker of symptomatic patent ductus arteriosus in preterm infants]. Lu KS, Guo XL, Lv JF, Huang SL, Yang CH, Zou ZH, Chen ZJ, Lai CH, Yang BY. Zhongguo Dang Dai Er Ke Za Zhi; 2015 Nov; 17(11):1160-4. PubMed ID: 26575871 [Abstract] [Full Text] [Related]
17. N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants. Nuntnarumit P, Khositseth A, Thanomsingh P. J Perinatol; 2009 Feb; 29(2):137-42. PubMed ID: 19020527 [Abstract] [Full Text] [Related]